December 10th 2024
An analysis of patient reported outcome measures from 3 pivotal phase 3 RCTs of atogepant 60 mg demonstrates efficacy across functional domains as well as for migraine prevention.
October 29th 2024
Ulcerative Colitis Patients Feel Much Worse Than Their Doctors Think
April 6th 2012Ulcerative colitis has a greater impact on patients’ quality of life than physicians perceive, and the disease affects their lives even more than the impact of other chronic conditions, according to paired surveys of doctors and patients.
Teenager With One-Sided Facial Flushing and Progressive Vision Loss in Left Eye
October 6th 2010Sixteen-year-old African American boy with progressive loss of vision in the left eye over 2 weeks. He also had pain around the left orbit with some radiation to the temple. His mother reported that one side of his face appeared to be more flushed when he exerted himself; he had not seen a physician for this problem. He had no seizures or hemiparesis and was cognitively intact.
Older Man With Visual Symptoms of Acute Onset
May 5th 2010For more than a week, a 74-year-old man has had diminished vision in his left eye. He reports that the problem started acutely with a sensation of flashing lights in the affected eye, followed by the presence of dark floaters for several days.
Migraine, Chronic Daily Headache, and Complex Regional Pain Syndrome: Researchers Establish Links
September 16th 2009Migraine and chronic daily headache may be risk factors for the development of complex regional pain syndrome, according to the results of a study led by B. Lee Peterlin, DO, assistant professor of neurology, Drexel University College of Medicine in Philadelphia.
Migraine as Inspiration in Painting
September 16th 2009Did Pablo Picasso suffer from migraine? And did these episodes influence his artwork? Not likely, said Joost Haan, MD, PhD, a member of the department of neurology at Leiden University Medical Centre, Leiden, the Netherlands. He discussed migraine and the works of master painters at the 14th annual International Headache Congress in Philadelphia.
Large Study Shows onabotulinumtoxinA to Be Effective for Chronic Migraine Treatment and Prophylaxis
September 15th 2009Results of a landmark study showed that onabotulinumtoxinA effectively reduced headache symptoms, episodes, disability, and health-related quality of life in patients with chronic migraine.
Study Shows Migraineurs With Comorbid Mood Disorders Responded Well to Treatment
September 15th 2009Patients with migraine accompanied by depression or anxiety disorders had greater improvements in headache-related disability than those without a psychiatric disorder, according to results of the Treatment of Severe Migraine trial.
Chronic Daily Headache Is Prevalent Among Soldiers With Mild Head Trauma
September 15th 2009About 20% of soldiers returning from Iraq and Afghanistan who have a history of concussion or blast exposure experience chronic daily headache, according to a results of study presented at the 14th annual International Headache Congress in Philadelphia.
Headache in the Movies: Inaccurate Portrayals Lead to Patient Fears and Misunderstandings
September 15th 2009The portrayal of headache in film may contribute to patients’ misconceptions and fears about their illness, according to Bert B. Vargas, MD, clinical professor of neurology at the Mayo Clinic in Phoenix.
Tonabersat May Be Helpful for the Prevention of Aura Associated With Migraine
September 11th 2009Tonabersat is effective in the prophylaxis of aura in patients with migraine, according to a recent study led by Jes Olesen, MD, a professor of neurology at the Danish Headache Center at Glostrup Hospital, University of Copenhagen, Glostrup, Denmark.